Both in Pharmaceuticals
Agios Pharmaceuticals vs Zenas BioPharma
Over the past year AGIO returned −21.6% and ZBIO returned −5.0%; their daily moves had a correlation of 0.09.
AGIO −21.6% ZBIO −5.0%Growth of $1, one year, split-adjusted
| Metric | AGIO | ZBIO |
|---|---|---|
| Price | $31.38 | $28.46 |
| Market cap | $1.87B | $1.85B |
| Today | +0.58% | +0.28% |
| 1 month | −1.1% | +5.6% |
| 6 months | +16.3% | +36.6% |
| Year to date | +15.3% | −21.6% |
| 1 year | −21.8% | −9.2% |
| Revenue growth (YoY) | +259.3% | — |
| Gross margin | 93.3% | 100.0% |
| Net margin | −225.1% | −11145.6% |
| P/E (TTM) | — | — |
| Price / sales | 19.1× | 1,854.9× |
| Net cash | $617.6M | $346.1M |
| Dividend yield | — | — |
| Volatility (60d) | 58.0% | 55.8% |
| Short % of float | 12.2% | 40.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).